Literature DB >> 4868587

Cytotoxic drugs in pregnancy. Review of reported cases.

H O Nicholson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4868587     DOI： 10.1111/j.1471-0528.1968.tb02083.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Br Commonw        ISSN： 0022-3204


× No keyword cloud information.
  12 in total

1.  Cancer chemotherapy during pregnancy. Consortium of cancer in pregnancy evidence.

Authors:  M Lishner; G Koren
Journal:  Can Fam Physician       Date:  2001-01       Impact factor: 3.275

2.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

3.  [Cytostatic therapy in breast carcinoma].

Authors:  K Karrer
Journal:  Langenbecks Arch Chir       Date:  1970-12

Review 4.  Treating breast cancer during pregnancy. What can be taken safely?

Authors:  M Espié; C Cuvier
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

5.  Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists.

Authors:  Sophie E McGrath; Alistair Ring
Journal:  Ther Adv Med Oncol       Date:  2011-03       Impact factor: 8.168

Review 6.  Pregnancy related issues in inflammatory bowel disease: evidence base and patients' perspective.

Authors:  Christian P Selinger; Rupert Wl Leong; Simon Lal
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 7.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

8.  Pregnancies following conservative treatment of malignant ovarian tumors.

Authors:  K Shiromizu; T Kawana; M Sugase; K Takizawa; K Kawagoe; R Izumi; M Mizuno
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

Review 9.  Optimisation of antirheumatic drug treatment in pregnancy.

Authors:  M Ostesen
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

10.  Contragestational profile of the tumor-inhibiting agent, L-alanosine, in the rat and the hamster.

Authors:  G Galliani; A Assandri; D Barone; M Grandi; G Mistrello; G C Lancini
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.